Please login to the form below

Cornerstone Therapeutics

This page shows the latest Cornerstone Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Chiesi hits the acquisition trail again

Chiesi hits the acquisition trail again. Will buy US speciality pharma company Cornerstone. ... Italy's Chiesi has signed its second acquisition deal in as many months, agreeing a $9.50-a-share deal for US speciality pharma company Cornerstone

Latest news

Cornerstone slumps as FDA panel votes down lead pipeline drug

US pharma company Cornerstone Therapeutics suffered a setback after an FDA advisory committee voted against approval of lixivaptan, the firm's drug candidate for hyponatremia or low sodium levels in the ... It was originally developed by Wyeth and
Pharma deals for May 2012

This can effectively kill a deal and potentially the product. Another example of a product acquisition is InterMune's sale of its approved product, Actimmune (interferon gamma-1b), to Vidara Therapeutics ... NCEs for respiratory disease. 212. EKR
Biologics buoyant

Three of the deals, with Amplimmune, FivePrime Therapeutics and Genmab, focus on biologics. ... 84+. Cornerstone Therapeutics/Targacept . Alpha-7 and other nicotinic receptor targeting compounds. Preclinical .

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest Intelligence

Deal Watch table for September 2013

Cornerstone Therapeutics/ Chiesi Farmaceutici. Acquisition (42 per cent). US speciality pharmaceutical company focused hospital and niche respiratory products. ... Cornerstone Therapeutics, respectively.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Project / Account Manager (Medical Education): Salary TBC

Account Director: £48, 000 - £60, 000

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Associate Director, Market Access & HEOR – North-West: Negotiable

Medical/ Scientific Director: Salary TBC

SENIOR MEDICAL WRITER IN ONCOLOGY: Up to £60, 000.00 pension bonus

Associate Medical Director: Highly Competitive

Events Manager – Med Comms – Surrey: Salary TBC

SAM – Health Behaviour/ Patient Adherence Healthcare Agency: Salary TBC

Digital Manager, London – Healthcare Brandcomms, Medcomms, PR: Excellent package

Medical Writers Required – Cheshire: DOE

Senior Account Managers - Oxfordshire: Attractive salary and benefits package offered

Account Manager – Creative Healthcare Advertising – Central Lond...: Salary TBC

Senior Account Manager- Central Oxford and Abingdon: Negotiable

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Senior Account Director development role to Business Director, H...: Excellent package

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Senior Account Manager > Account Director - London - Medical ...: Salary TBC

Senior Medical Writer: Great salary and benefits

Programme Director, Healthcare PR, Highly competitive package: Highly Competitive package

Senior Medical Writer: Competitive Salary

Consultant Health Economics - London / Oxford: Negotiable

Account Manager / Account Director: Competative

Client Services Director – Medical Education Agency – North West...: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award: The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare: Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer: Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...